Compare · DGX vs ELV
DGX vs ELV
Side-by-side comparison of Quest Diagnostics Incorporated (DGX) and Elevance Health Inc. (ELV): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DGX and ELV operate in Medical Specialities (Health Care), so they compete in similar markets.
- ELV is the larger of the two at $81.74B, about 3.8x DGX ($21.50B).
- Over the past year, DGX is up 9.8% and ELV is down 7.8% - DGX leads by 17.6 points.
- DGX has been more active in the news (15 items in the past 4 weeks vs 7 for ELV).
- DGX has more recent analyst coverage (25 ratings vs 22 for ELV).
- Company
- Quest Diagnostics Incorporated
- Elevance Health Inc.
- Price
- $194.50+2.83%
- $376.62-0.02%
- Market cap
- $21.50B
- $81.74B
- 1M return
- -0.78%
- +28.60%
- 1Y return
- +9.78%
- -7.78%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NYSE
- IPO
- News (4w)
- 15
- 7
- Recent ratings
- 25
- 22
Quest Diagnostics Incorporated
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Latest DGX
- SEC Form FWP filed by Quest Diagnostics Incorporated
- Quest Diagnostics Prices $500 Million of Senior Notes
- Executive Vice President & CFO Samad Sam was granted 108 shares, increasing direct ownership by 0.32% to 33,376 units (SEC Form 4)
- SVP for Diagnostic Services Plewman Patrick increased direct ownership by 0.32% to 15,247 units (SEC Form 4)
- Director Gregg Vicky B was granted 68 shares, increasing direct ownership by 0.40% to 17,172 units (SEC Form 4)
- Director Carter Robert B increased direct ownership by 0.26% to 2,711 units (SEC Form 4)
- Director Lassiter Wright Iii increased direct ownership by 0.07% to 9,063 units (SEC Form 4)
- SVP, Clinical Solutions Kuppusamy Karthik increased direct ownership by 0.29% to 13,490 units (SEC Form 4)
- SVP & Chief Commercial Officer Delaney Mark E increased direct ownership by 0.31% to 11,901 units (SEC Form 4)
- SEC Form 10-Q filed by Quest Diagnostics Incorporated
Latest ELV
- Elevance Health's Affiliated Health Plans Deliver More Predictable, Lower Healthcare Costs for Small Businesses
- Elevance Health upgraded by BofA Securities with a new price target
- SEC Form 10-Q filed by Elevance Health Inc.
- Elevance Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Elevance Health Reports First Quarter 2026 Results; Raises Full-Year Guidance
- Evercore ISI initiated coverage on Elevance Health with a new price target
- SEC Form PX14A6G filed by Elevance Health Inc.
- Elevance Health Announces Leadership Appointments to Strengthen Execution and Drive Growth
- Elevance Health to Hold Conference Call and Webcast to Discuss First Quarter 2026 Results on April 22, 2026
- SEC Form DEFA14A filed by Elevance Health Inc.